Status:
COMPLETED
In Vitro Follicle Activation in Patient With Premature Ovarian Failure Under 36 Years Old
Lead Sponsor:
Hacettepe University
Collaborating Sponsors:
St. Marianna University School of Medicine
Stanford University
Conditions:
Activation of Primordial Follicles
Eligibility:
FEMALE
18-36 years
Phase:
NA
Brief Summary
This is a clinical trial that the investigators aim to validate In-vitro Activation (IVA) treatment protocol, which was previously defined by Kazuhiro Kawamura (MD) and Aaron Hsueh (PhD), in Turkish p...
Detailed Description
The objectives of the study is as following; * Validation of the previously defined In-Vitro Activation Protocol approach in Turkish patients under 36 years old with Premature Ovarian Insufficiency (...
Eligibility Criteria
Inclusion
- Patient with POI
- Short amenorrhea period (1 - 2 years)
Exclusion
- Having been treated with chemotherapy and/or radiotherapy;
- Having been diagnosed with advanced stage of endometriosis (endometriomas)
- Having been diagnosed with the chronic diseases such as diabetes, cardiac failure, kidney insufficiency, morbid obesity etc..
- Presence of chromosomal abnormality (Turner, Fragile-X etc.)
- Previous multiple laparotomies
- Menopause \>10 years
- Accompanied azoospermia
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04131244
Start Date
December 1 2017
End Date
December 15 2019
Last Update
February 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University School of Medicine, Department of Ob/Gyn
Ankara, Turkey (Türkiye), 06100